Javier E Banchs

Summary

Affiliation: Pennsylvania State University
Country: USA

Publications

  1. ncbi Intracardiac echocardiography in complex cardiac catheter ablation procedures
    Javier E Banchs
    Penn State Heart and Vascular Institute, Penn State University College of Medicine, 500 University Drive, H047, Hershey, PA 17033, USA
    J Interv Card Electrophysiol 28:167-84. 2010
  2. ncbi Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies
    Giselle A Baquero
    Heart and Vascular Institute, Penn State College of Medicine, Hershey, Pennsylvania, USA
    J Cardiovasc Electrophysiol 23:296-301. 2012
  3. ncbi Vernakalant: pharmacology electrophysiology, safety and efficacy
    Gerald V Naccarelli
    Division of Cardiology, Penn State University Heart and Vascular Institute, Penn State University College of Medicine, Hershey, PA 17033, USA
    Drugs Today (Barc) 44:325-9. 2008
  4. ncbi Efficacy and safety of dofetilide in patients with atrial fibrillation and atrial flutter
    Javier E Banchs
    Penn State Heart and Vascular Institute, Milton S Hershey Medical Center, Penn State University, 500 University Drive, P O Box 850, Hershey, PA, 17033 0850, USA
    J Interv Card Electrophysiol 23:111-5. 2008
  5. ncbi A review of the appropriate and inappropriate use of dronedarone: lessons learned from controlled studies and regulatory submission
    Gerald V Naccarelli
    Heart and Vascular Institute, Penn State University College of Medicine, Hershey, PA, USA
    J Cardiovasc Pharmacol Ther 15:24S-30S. 2010
  6. ncbi Vernakalant--a promising therapy for conversion of recent-onset atrial fibrillation
    Gerald V Naccarelli
    Penn State University College of Medicine, Division of Cardiology, 500 University Dr Room H 1 511, Hershey, PA 17033, USA
    Expert Opin Investig Drugs 17:805-10. 2008
  7. ncbi Safety and efficacy of dronedarone in the treatment of atrial fibrillation/flutter
    Gerald V Naccarelli
    Penn State Hershey Heart and Vascular Institute, Cardiac Electrophysiology Program, Hershey, PA, USA
    Clin Med Insights Cardiol 5:103-19. 2011
  8. ncbi Distal balloon occlusion allows epicardial lead placement in a tortuous branch of the great cardiac vein
    Parag Patel
    Penn State Heart and Vascular Institute, Milton S Hershey Medical Center, Hershey, PA, USA
    J Interv Card Electrophysiol 25:159-61. 2009
  9. ncbi New antiarrhythmic treatment of atrial fibrillation
    Gerald V Naccarelli
    Penn State University Heart and Vascular Institute, The Electrophysiology Program, Penn State University College of Medicine, The Milton S Hershey Medical Center, 500 University Dr, Room H 1 511, Hershey, PA 17033, USA
    Expert Rev Cardiovasc Ther 5:707-14. 2007
  10. ncbi Paroxysmal atrioventricular block following a ventricular premature beat
    Javier E Banchs
    Heart and Vascular Institute, Milton S. Hershey Medical Center, Penn State College of Medicine, Hershey, Pennsylvania 17033-0850, USA
    J Cardiovasc Electrophysiol 18:230. 2007

Collaborators

Detail Information

Publications10

  1. ncbi Intracardiac echocardiography in complex cardiac catheter ablation procedures
    Javier E Banchs
    Penn State Heart and Vascular Institute, Penn State University College of Medicine, 500 University Drive, H047, Hershey, PA 17033, USA
    J Interv Card Electrophysiol 28:167-84. 2010
    ....
  2. ncbi Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies
    Giselle A Baquero
    Heart and Vascular Institute, Penn State College of Medicine, Hershey, Pennsylvania, USA
    J Cardiovasc Electrophysiol 23:296-301. 2012
    ..Dofetilide has only been approved for the treatment of atrial fibrillation. The role of dofetilide in the control of ventricular arrhythmias in patients with an ICD has not been established...
  3. ncbi Vernakalant: pharmacology electrophysiology, safety and efficacy
    Gerald V Naccarelli
    Division of Cardiology, Penn State University Heart and Vascular Institute, Penn State University College of Medicine, Hershey, PA 17033, USA
    Drugs Today (Barc) 44:325-9. 2008
    ..In addition, preliminary data suggest that it could also suppress recurrences when used orally. This paper reviews the pharmacology, electrophysiology, efficacy and safety of intravenous and oral vernakalant...
  4. ncbi Efficacy and safety of dofetilide in patients with atrial fibrillation and atrial flutter
    Javier E Banchs
    Penn State Heart and Vascular Institute, Milton S Hershey Medical Center, Penn State University, 500 University Drive, P O Box 850, Hershey, PA, 17033 0850, USA
    J Interv Card Electrophysiol 23:111-5. 2008
    ..It is not known, however, whether pharmacological conversion with dofetilide predicts maintenance of sinus rhythm. In addition, there is limited information comparing the efficacy of dofetilide in persistent versus paroxysmal AF/AFL...
  5. ncbi A review of the appropriate and inappropriate use of dronedarone: lessons learned from controlled studies and regulatory submission
    Gerald V Naccarelli
    Heart and Vascular Institute, Penn State University College of Medicine, Hershey, PA, USA
    J Cardiovasc Pharmacol Ther 15:24S-30S. 2010
    ..Dronedarone is a novel, multichannel blocking antiarrhythmic agent that may have some pleiotropic effects in addition to its ability to suppress and maintain sinus rhythm and control the rate during AF/AFL recurrences...
  6. ncbi Vernakalant--a promising therapy for conversion of recent-onset atrial fibrillation
    Gerald V Naccarelli
    Penn State University College of Medicine, Division of Cardiology, 500 University Dr Room H 1 511, Hershey, PA 17033, USA
    Expert Opin Investig Drugs 17:805-10. 2008
    ..In addition, this drug has important rate-dependent sodium channel blocking properties...
  7. ncbi Safety and efficacy of dronedarone in the treatment of atrial fibrillation/flutter
    Gerald V Naccarelli
    Penn State Hershey Heart and Vascular Institute, Cardiac Electrophysiology Program, Hershey, PA, USA
    Clin Med Insights Cardiol 5:103-19. 2011
    ..In addition, the recent results of the PALLAS trial suggest that dronedarone should not be used in the long-term treatment of patients with permanent AF...
  8. ncbi Distal balloon occlusion allows epicardial lead placement in a tortuous branch of the great cardiac vein
    Parag Patel
    Penn State Heart and Vascular Institute, Milton S Hershey Medical Center, Hershey, PA, USA
    J Interv Card Electrophysiol 25:159-61. 2009
    ..This approach can be used in navigating lead placement to branches thought to be unreachable. Techniques such as this can decrease the failure rate of CRT implants...
  9. ncbi New antiarrhythmic treatment of atrial fibrillation
    Gerald V Naccarelli
    Penn State University Heart and Vascular Institute, The Electrophysiology Program, Penn State University College of Medicine, The Milton S Hershey Medical Center, 500 University Dr, Room H 1 511, Hershey, PA 17033, USA
    Expert Rev Cardiovasc Ther 5:707-14. 2007
    ..Future studies will clarify the role of these drugs in treating AF...
  10. ncbi Paroxysmal atrioventricular block following a ventricular premature beat
    Javier E Banchs
    Heart and Vascular Institute, Milton S. Hershey Medical Center, Penn State College of Medicine, Hershey, Pennsylvania 17033-0850, USA
    J Cardiovasc Electrophysiol 18:230. 2007